Related Experiment Videos
The peptide-binding strategy of the MHC class II I-A molecules
B Reizis1, M Eisenstein, F Mor
1Dept of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Immunology Today
|June 5, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phenotypic shift of small intestinal intra-epithelial type 1 innate lymphoid cells in celiac disease is associated with enhanced cytotoxic potential.
Clinical and experimental immunology·2020
Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
Journal of veterinary internal medicine·2015
Vaccination against autoimmune disease with lines of autoimmune T lymphocytes.
Immunology today·2014
Natural autoantibodies might prevent autoimmune disease.
Immunology today·2014
The advantage of being a low responder.
Immunology today·2014
The origin and significance of anti-DNA antibodies.
Immunology today·2014
Mutations of class II MHC molecules.
Immunology today·2014
Antigen processing at the molecular level.
Immunology today·2014
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.
Immunology today·2014
Are MHC class II-restricted cytotoxic T lymphocytes important?
Immunology today·2014
Complement and the regulation of humoral immune responses.
Immunology today·2014
Bacillus Calmette-Guerin in controlling type 1 diabetes: A quasi-experimental randomized clinical trial.
Caspian journal of internal medicine·2026
Telemedicine-guided management of iodinated contrast media-associated anaphylaxis: A case report.
Radiology case reports·2026
Hybridoma-based generation of a functional IgM antibody targeting the 160-loop of influenza B virus haemagglutinin.
Journal of immunological methods·2026
Management of hyperthyroidism in pregnancy.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Photodynamic activities of silicon (IV) phthalocyanines with different charges and their synergistic efficacy with immunotherapy.
International immunopharmacology·2026